SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-028831
Filing Date
2016-04-01
Accepted
2016-04-01 08:30:26
Documents
3
Period of Report
2016-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20160331_8k.htm 8-K 28930
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 16626
3 diff.jpg GRAPHIC 5651
  Complete submission text file 0001437749-16-028831.txt   55021
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24477 | Film No.: 161545122
SIC: 2834 Pharmaceutical Preparations